NASHVILLE, Tenn.–(BUSINESS WIRE)–Virtuoso Surgical, Inc., a Nashville based medical device company, is pleased to announce their role in a landmark, multi-institution award from the federal Advanced Research Projects Agency for Health (ARPA-H) program to advance Autonomy at a Less Invasive Scale in Surgery (ALISS) (https://arpa-h.gov/research-and-funding/mission-office-iso/awardees) and enable fully autonomous surgical procedures. The award provides up … [Read more…]

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the facial aesthetic appearance of patients experiencing medication-driven weight loss with associated facial volume loss1 A six-month extension study is ongoing to capture the combined and sustained effects of these treatments over time Galderma is well-positioned … [Read more…]

SLP’s technology and expertise accelerates drug development and supports critical advancements in global healthcare RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today highlighted its impact on the pharmaceutical industry through supporting the development … [Read more…]

FORT WORTH, Texas–(BUSINESS WIRE)–Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter and full year 2024, before market open on Thursday, February 6, 2025. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. … [Read more…]

GOLETA, Calif.–(BUSINESS WIRE)–$INGN #AirwayClearance—Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the fourth quarter and the full year ended December 31, 2024. The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2024 to be in … [Read more…]

The partnership connects the scrub brand to a leading national distributor LOS ANGELES & BOLINGBROOK, Ill.–(BUSINESS WIRE)–Premium scrubwear brand Jaanuu continues to broaden its reach, establishing a new partnership with S&S Activewear (S&S), a leading technology-enabled distributor of apparel and accessories in the United States and Canada. S&S operates eight nationwide distribution centers and has … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cancer Immunotherapy – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. The global market for Cancer Immunotherapy is estimated at US$135.2 billion in 2024 and is anticipated to post a CAGR of 9.8% during the 2024-2030 analysis period and stand at a projected US$236.9 billion by 2030. The global cancer … [Read more…]

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizophrenia in adults sNDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has potential to become a standard of … [Read more…]

PARIS–(BUSINESS WIRE)–Egle Therapeutics, a clinical-stage biotechnology company advancing the next generation of regulatory T cell (Treg)-focused therapies for oncology and autoimmune diseases, today announced the appointment of experienced biotechnology industry executive, Christophe Quéva, Ph.D., as Chief Executive Officer (CEO). With over 20 years of experience in the biotechnology industry, Dr. Quéva brings a wealth of … [Read more…]

Strong investor syndicate backs clinical-stage Hepatitis B program while advancing pioneering gene-tuning platform DURHAM, N.C. & SEATTLE–(BUSINESS WIRE)–Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and Hevolution Foundation. “It is deeply gratifying to have seen this platform and company … [Read more…]